Market Analysis:

The global Paronychia Treatment Market Share is predicted to grow at an 11.7% CAGR over the forecast period (2017-2023), states the new Market Research Future (MRFR) report. Paronychia, simply put, is a skin infection that develops surrounding the nail. This happens when fungi or bacteria gets under the skin. It can result from chewing or biting the nails, yet it is common during working conditions that need the hands in being frequently exposed to chemicals or is frequently wet. Most often, paronychia is not a serious condition, and there are many effective treatments. This skin infection results in discomfort, swelling, and inflammation around the nail. In paronychia abscesses having pus may also form.

Various factors are propelling the Paronychia Treatment Market Size. Some of these factors according to the Market Research Future (MRFR) report, include growing expenditure on research and development activities, rising incidence of infections as well as related complications, growing awareness among people, and changing reimbursement policies. Geriatric population, the scope for emerging players, revised reimbursement policies by the government, and demand for innovative drug development methods are also propelling the market growth.

On the flip side, various side effects related to the drugs and availability of spurious and misbranded drugs are factors that may deter the paronychia treatment market Size over the forecast period.

Key Players:
• Perrigo New York
• Taro Pharmaceutical Industries Ltd
• Fougera Pharmaceuticals Inc
• Jonakayem Pharma Formulation Pv
• Eli Lilly Company
• Teva Pharmaceutical Industries Ltd
• Glenmark Generics Ltd
• GlaxoSmithKline plc

Market Segmentation:

• The MRFR report provides a complete segmental analysis of the paronychia treatment market on the basis of end user, application, and type.

• Based on type, the paronychia treatment market is segmented into pyogenic paronychia, candida paronychia, chronic paronychia, acute paronychia, and others.

• Based on application, the paronychia treatment market is segmented into dicloxacillin, gentamicin ointment, fusidic acid ointment, mupirocin ointment, and others.

• Based on end user, the paronychia treatment market is segmented into dermatology center, hospitals and clinics, and others.

Regional Analysis:

By region, the paronychia treatment market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will have the lion’s share in the market over the forecast period. Factors aiding growth in the region include growing prevalence of pyogenic paronychia, candida paronychia, chronic paronychia, and acute paronychia, growing support from the government for R&D activities, well-developed technology, changing lifestyle, and high healthcare expenditure. Moreover, the presence of key players in the region is also accelerating market growth.

The paronychia treatment market in Europe will have the second-largest share over the forecast period. Factors aiding growth in the region include strong government support, availability of funds for R&D activities, and the presence of several key players in the region.

The paronychia treatment market in the APAC region is predicted to grow at the fastest pace over the forecast period. Factors aiding growth in the region include increasing government support, rapidly developing economy, and growing healthcare awareness. Moreover, growing demand for new treatments in South Korea and India, increasing patient population, and government in the developing countries focusing on quality treatment to improve the citizens’ living standard.